|Posted: 2018-Aug-02 17:23 by Predator Research|
|Posted: 2018-Aug-02 17:24 by news bot|
U.S. chemicals producer DowDuPont reported better-than-expected profit for the fourth straight quarter, driven by higher prices and strong demand for its products including paints and packaging materials.
Net sales rose 17 percent to $24.2 billion, which the company said compares with net sales of $20.7 billion that DowDuPont would have made had it been one company in the same quarter a year earlier. Adjusted earnings came in at $1.37 per share, an increase of 41 percent. Analysts on average were expecting the company to report a profit of $1.30 per share on revenue of $23.6 billion.
|Posted: 2018-Aug-03 13:21 by news bot|
The company has informed India it is putting off trials needed for approval to sell a genetically modified variety of corn, taking a cue from U.S. rival Monsanto that has also pulled a similar application due to intellectual property concerns. In a letter addressed to India's environment ministry reviewed by Reuters, the Indian arm of DowDuPont said it had obtained permission to conduct trials growing a small crop of the corn in the northern state of Punjab but would like to "defer the undertaking". "This is to confirm that we have deferred the Biosafety Research Level-I confined field trials with transgenic maize planned during the season of kharif 2018," a DowDuPont spokeswoman told Reuters in an email, referring to the summer planting season. "The company remains committed to advancing agricultural productivity in India."
|Posted: 2018-Sep-20 13:50 by news bot|
CEO Edward Breen is set to take over as Chairman of its specialty products unit after the company completes a restructuring following the $130B merger of Dow and DuPont last September. The company plans to separate into three trading units focused on agriculture, plastics and specialty products.